Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 9 Myeloid 6 Classical hematology 2 Plasma cell 1 Lymphoid 1

Conditions

Multiple Myeloma 3073 Neoplasms, Plasma Cell 614 Lymphoma 455 Lymphoma, Non-Hodgkin 428 Recurrence 368 Hodgkin Disease 366 Leukemia, Lymphocytic, Chronic, B-Cell 362 Precursor Cell Lymphoblastic Leukemia-Lymphoma 340 Leukemia, Myeloid, Acute 322 Leukemia 321 Myelodysplastic Syndromes 287 Lymphoma, Mantle-Cell 262 Lymphoma, Large B-Cell, Diffuse 259 Lymphoma, Follicular 254 Lymphoma, B-Cell, Marginal Zone 231 Burkitt Lymphoma 227 Lymphoma, Large-Cell, Immunoblastic 203 Myeloproliferative Disorders 197 Neoplasms 181 Immunoglobulin Light-chain Amyloidosis 181 Hematologic Neoplasms 169 Primary Myelofibrosis 167 Leukemia, Myeloid, Chronic-Phase 165 Leukemia, Myeloid, Accelerated Phase 154 Lymphoma, T-Cell, Cutaneous 150 Waldenstrom Macroglobulinemia 145 Blast Crisis 143 Leukemia, Myelomonocytic, Chronic 140 Mycosis Fungoides 129 Sezary Syndrome 128

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × GATA2 Deficiency × Plasma cell × Clear all

NCT03018405 2019-09-19

THINK

Celyad Oncology SA

Phase 1/2 Unknown

GATA2 Deficiency, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡